Procaine (Novocaine): Mechanism, Uses, and Modern Context

Overview

Procaine (brand Novocaine) is an ester-type local anesthetic introduced in 1905. It revolutionized dentistry and minor surgery by enabling painless procedures.

Mechanism of Action

Binds intracellular site of voltage-gated Na⁺ channels (use-dependent) → prevents depolarization → blocks action potential propagation in sensory nerves.

Pharmacokinetics

• Rapid hydrolysis by plasma pseudocholinesterase → PABA + DEA (half-life ~1 min).
• Short duration (30–60 min infiltration; 60–90 min with epinephrine).
• Low lipid solubility → less cardiotoxic than amides.

Clinical Uses

• Dental infiltration/block anesthesia.
• Minor cutaneous procedures, biopsies.
• Spinal/epidural (historical; replaced by lidocaine, bupivacaine).
• Diagnostic blocks.

Adverse Effects

• Allergy (rare; PABA metabolite, Type I/IV).
• CNS toxicity (seizures) at high systemic levels.
• Methemoglobinemia (rare, with large doses).

Current Status

Largely superseded by amide anesthetics (lidocaine, articaine) with longer duration, lower allergy risk, and no pseudocholinesterase dependence. Still used where short action or ester preference desired.